MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, SANA has $373,593K in assets. $254,353K in debts. $83,800K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
129.47%
Quick Ratio
129.47%
Cash Ratio
97.14%
Debt to Asset Ratio
68.08%
Unit: Thousand (K) dollars
Assets Breakdown
    • Goodwill
    • Cash and cash equivalents
    • Intangible asset
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Contingent consideration, net of...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
83,800 71,870 103,357 71,271
Marketable securities
17,336 66,512 49,697 1,403
Restricted cash
4,195 4,195 4,195 4,195
Prepaid expenses and other current assets
6,359 6,099 4,510 5,633
Total current assets
111,690 148,676 161,759 82,502
Property and equipment, at cost
82,819 81,661 83,774 -
Less accumulated depreciation
57,146 54,755 53,843 -
Property and equipment, net
25,673 26,906 29,931 33,081
Operating lease right-of-use assets
35,845 38,313 40,704 43,021
Intangible asset
59,195 59,195 59,195 59,195
Goodwill
140,627 140,627 140,627 140,627
Other non-current assets
563 3,173 3,216 3,219
Total assets
373,593 416,890 435,432 361,645
Accounts payable
2,123 1,669 1,858 2,270
Accrued compensation
7,584 13,240 11,296 9,411
Accrued expenses and other current liabilities
8,124 8,679 7,991 7,931
Operating lease liabilities
14,878 14,938 14,368 13,832
Contingent consideration
53,556 40,200 --
Total current liabilities
86,265 78,726 35,513 33,444
Operating lease liabilities, net of current portion
60,450 63,924 67,868 71,660
Contingent consideration, net of current portion
80,907 83,518 115,141 117,132
Success payment liabilities
16,926 19,238 13,726 8,611
Other non-current liabilities
9,805 10,600 7,876 8,242
Total liabilities
254,353 256,006 240,124 239,089
Common stock, 0.0001 par value 750,000 shares authorized 269,817 and 266,732 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
27 27 26 23
Additional paid-in capital
2,015,441 2,009,845 1,985,452 1,870,572
Accumulated other comprehensive income (loss)
-2 28 21 0
Accumulated deficit
-1,896,226 -1,849,016 -1,790,191 -1,748,039
Total stockholders' equity
119,240 160,884 195,308 122,556
Total liabilities and stockholders' equity
373,593 416,890 435,432 361,645
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$83,800K Marketable securities$17,336K Prepaid expenses andother current assets$6,359K Restricted cash$4,195K Property and equipment,at cost$82,819K Goodwill$140,627K Total current assets$111,690K Intangible asset$59,195K Operating leaseright-of-use assets$35,845K Property and equipment,net$25,673K Other non-currentassets$563K Less accumulateddepreciation$57,146K Total assets$373,593K Total liabilities andstockholders' equity$373,593K Total liabilities$254,353K Total stockholders'equity$119,240K Accumulated deficit-$1,896,226K Accumulated othercomprehensive income (loss)-$2K Total currentliabilities$86,265K Contingent consideration,net of current...$80,907K Operating leaseliabilities, net of current...$60,450K Success paymentliabilities$16,926K Other non-currentliabilities$9,805K Additional paid-in capital$2,015,441K Common stock, 0.0001par value 750,000...$27K Contingent consideration$53,556K Operating leaseliabilities$14,878K Accrued expenses andother current...$8,124K Accrued compensation$7,584K Accounts payable$2,123K

Sana Biotechnology, Inc. (SANA)

Sana Biotechnology, Inc. (SANA)